Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds

被引：25

作者：

Dhar, T. G. Murali ^{[1
]}

Wrobleski, Stephen T. ^{[1
]}

Lin, Shuqun ^{[1
]}

Furch, Joseph A. ^{[1
]}

Nirschl, David S. ^{[1
]}

Fan, Yi ^{[1
]}

Todderud, Gordon ^{[1
]}

Pitt, Sidney ^{[1
]}

Doweyko, Arthur M. ^{[1
]}

Sack, John S. ^{[1
]}

Mathur, Arvind ^{[1
]}

McKinnon, Murray ^{[1
]}

Barrish, Joel C. ^{[1
]}

Dodd, John H. ^{[1
]}

Schieven, Gary L. ^{[1
]}

Leftheris, Katerina ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 18期

关键词：

p38; alpha; MAP kinase inhibitors; TNF alpha; X-ray co-crystallography;

D O I：

10.1016/j.bmcl.2007.07.029

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and structure-activity relationships (SAR) of p38 alpha MAP kinase inhibitors based on heterobicyclic scaffolds are described. This effort led to the identification of compound (21) as a potent inhibitor of p38a MAP kinase with good cellular potency toward the inhibition of TNF-alpha production. X-ray co-crystallography of an oxalamide analog (24) bound to unphosphorylated p38 alpha is also disclosed. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：5019 / 5024

页数：6

共 50 条

[41] Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors
Karcher, Solveigh C.
Laufer, Stefan A.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (07) : 655 - 676
[42] Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors
Park, Hwangseo
Lee, Soyoung
Hong, Sungwoo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (18) : 3784 - 3787
[43] Pyrazoloheteroaryls:: Novel p38α MAP kinase inhibiting scaffolds with oral activity
Revesz, L
Blum, E
Di Padova, FE
Buhl, T
Feifel, R
Gram, H
Hiestand, P
Manning, U
Neumann, U
Rucklin, G
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 262 - 266
[44] A practical synthesis of tetrasubstituted imidazole p38 MAP kinase inhibitors:: A new method for the synthesis of α-amidoketones
Murry, JA
Frantz, D
Frey, L
Soheili, A
Marcantonio, K
Tillyer, R
Grabowski, EJJ
Reider, PJ
CHEMICAL PROCESS RESEARCH: THE ART OF PRACTICAL ORGANIC SYNTHESIS, 2004, 870 : 161 - 180
[45] Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors
Sarma, Rituparna
Sinha, Sharat
Ravikumar, Muttineni
Kumar, Madala Kishore
Mahmood, S. K.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (12) : 2870 - 2876
[46] Process Research and Development for Heterocyclic p38 MAP Kinase Inhibitors
Thiel, Oliver R.
Achmatowicz, Michal
Milburn, Robert M.
SYNLETT, 2012, (11) : 1564 - 1574
[47] Amide-based inhibitors of p38α MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides
Tester, Richland
Tan, Xuefei
Luedtke, Gregory R.
Nashashibi, Imad
Schinzel, Kurt
Liang, Weiling
Jung, Joon
Dugar, Sundeep
Liclican, Albert
Tabora, Jocelyn
Levy, Daniel E.
Do, Steven
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2560 - 2563
[48] Allosteric and slow binding inhibitors of p38 MAP kinase.
Regan, J
Breitfelder, S
Cirillo, P
Gilmore, T
Graham, A
Hickey, E
Madwed, J
Moriak, M
Moss, N
Pargellis, C
Proto, A
Tong, L
Torcellini, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U683 - U683
[49] The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, KP
McCaffrey, PG
Hsiao, K
Pazhanisamy, S
Galullo, V
Bemis, GW
Fitzgibbon, MJ
Garon, PR
Murcko, MA
Su, MSS
CHEMISTRY & BIOLOGY, 1997, 4 (06): : 423 - 431
[50] p38 MAP kinase inhibitors: Many are made, but few are chosen
Dominguez, C
Powers, DA
Tamayo, N
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (04) : 421 - 430

← 1 2 3 4 5 →